Your browser doesn't support javascript.
Transcriptome in Human Mycoses
Transcriptomics in Health and Disease, Second Edition ; : 395-435, 2022.
Article in English | Scopus | ID: covidwho-2301705
ABSTRACT
Mycoses are infectious diseases caused by fungi, which incidence has increased in recent decades due to the increasing number of immunocompromised patients and improved diagnostic tests. As eukaryotes, fungi share many similarities with human cells, making it difficult to design drugs without side effects. Commercially available drugs act on a limited number of targets and have been reported fungal resistance to commonly used antifungal drugs. Therefore, elucidating the pathogenesis of fungal infections, the fungal strategies to overcome the hostile environment of the host, and the action of antifungal drugs is essential for developing new therapeutic approaches and diagnostic tests. Large-scale transcriptional analyses using microarrays and RNA sequencing (RNA-seq), combined with improvements in molecular biology techniques, have improved the study of fungal pathogenicity. Such techniques have provided insights into the infective process by identifying molecular strategies used by the host and pathogen during the course of human mycoses. This chapter will explore the latest discoveries regarding the transcriptome of major human fungal pathogens. Further we will highlight genes essential for host–pathogen interactions, immune response, invasion, infection, antifungal drug response, and resistance. Finally, we will discuss their importance to the discovery of new molecular targets for antifungal drugs. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2014, 2022.
Keywords
5-fluorouracil; A. fumigatus; Amphotericin B (AMB); Antifungal drug response; Antifungal drugs; Antifungal drugs target; Antimicrobial peptides (AMPs); Aspergillus; Aspergillus fumigatus; Blastomyces dermatitidis; Blastomycosis; Candida; Coccidioides immitis; COVID-19 pandemic; Cryptococcus gattii; Cryptococcus neoformans; Cytochrome P450; Cytosine permeasse; Dendritic cells; DNA/RNA metabolism; Drug-responsive genes; Epithelial barrier; Ergosterol; Ergosterol biosynthetic pathway; Filamentous; Fluconazole; Fungal infections; Fungi; Gene expression profile; Griseofulvin; High-throughput RNA sequencing (RNA-seq); Histoplasma capsulatum; Histoplasmosis; Host immune response; Host-pathogen interactions; Hyphae; ICAM1; Immune response; Immunocompromised patients; Infection; Infectious diseases; Invasion; Itraconazole; Ketoconazole; Large-scale transcriptional analyses; Macrophages; Major histocompatibility complex class II (MHC-II); Mannose-binding lectin; Metabolic adaptation; Microarrays; Microsporum gypseum; MRNAs; Mucosa; Mycoses; Neutrophils; Non-coding RNAs (ncRNAs); Nystatin; Paracoccidioides brasiliensis; Paracoccidioidomycosis; Parasitic phase; Pathogen-associated molecular patterns (PAMPs); Pattern-recognition receptors (PRRs); Phagocytes; Pofungin; Pro-inflammatory cytokines; Resistance; RNA; RNA sequencing (RNA-seq); ROS; RT-qPCR; Saprophytic phase; SARS-CoV-2; Small RNAs (sRNAs); Terbinafine (TRB); The transcription factor Relb; Trichophyton rubrum; Voriconazole; Yeast

Full text: Available Collection: Databases of international organizations Database: Scopus Language: English Journal: Transcriptomics in Health and Disease, Second Edition Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: Scopus Language: English Journal: Transcriptomics in Health and Disease, Second Edition Year: 2022 Document Type: Article